The role of ultrasound in molecular imaging

British Journal of Radiology

Volumn 76, Issue SPEC. ISS. 2, 2003, Pages

  Liang, H D ^a   Blomley, M J K ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AF 0150; CONTRAST MEDIUM; ECHO CONTRAST MEDIUM; FLUOROCARBON; FS 069; LIPOSOME; M 1134; M 1136; MP 1950; MRX 408; MRX 408A1; NUCLEAR FACTOR; OLIGODEOXYNUCLEOTIDE; PERFLEXANE; PLASMID DNA; SHU 508; UNCLASSIFIED DRUG;

BIOMICROSCOPY; CAPILLARY FLOW; CELL; CHEMICAL LABELING; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DOPPLER ECHOGRAPHY; DRUG DELIVERY SYSTEM; ECHOGRAPHY; FLOW RATE; GENE THERAPY; IMAGE PROCESSING; INJECTION; INTERVENTIONAL RADIOLOGY; NONHUMAN; REVIEW; SEDATION; VIRUS;

ANIMALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; MICROBUBBLES; MICROSCOPY, ACOUSTIC; MOLECULAR BIOLOGY; NEOVASCULARIZATION, PHYSIOLOGIC; ULTRASONOGRAPHY; ULTRASONOGRAPHY, DOPPLER;

EID: 8844285146     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/57063872     Document Type: Review

References (105)

1. Wells PNT. Physics and engineering: milestones in medicine. Med Eng Phys 2001;23:147-53.
2. Blomley MJK, Cooke JC, Unger EC, Monaghan MJ, Cosgrove DO. Science, medicine, and the future - microbubble contrast agents: a new era in ultrasound. Br Med J 2001;322:1222-5.
3. Blomley MJK, Sidhu PS, Cosgrove DO, Albrecht T, Harvey CJ, Heckemann RA, et al. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SHU 508A in the late liver phase? Early experience. Radiology 2001;220:661-7.
4. Schwarz KQ, Bezante GP, Chen XC, Schlief R. Quantitative echo contrast concentration measurement by doppler sonography. Ultrasound Med Biol 1993;19:289-97.
5. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-83.
6. Seidel G, Claassen L, Meyer K, Vidal-Langwasser M. Evaluation of blood flow in the cerebral microcirculation: analysis of the refill kinetics during ultrasound contrast agent infusion. Ultrasound Med Biol 2001;27:1059-64.
7. Mor-Avi V, Caiani EG, Collins KA, Korcarz CE, Bednarz JE, Lang RM. Combined assessment of myocardial perfusion and regional left ventricular function by analysis of contrast-enhanced power modulation images. Circulation 2001;104:352-7.
8. Turnbull DH, Bloomfield TS, Baldwin HS, Foster FS, Joyner AL. Ultrasound backscatter microscope analysis of early mouse embryonic brain-development. Proc Natl Acad Sci USA 1995;92:2239-43.
9. Aristizabal O, Christopher DA, Foster FS, Turnbull DH. 40-MHz echocardiography scanner for cardiovascular assessment of mouse embryos. Ultrasound Med Biol 1998;24:1407-17.
10. Srinivasan S, Baldwin HS, Aristizabal O, Kwee L, Labow M, Artman M, et al. Noninvasive, in utero imaging of mouse embryonic heart development with 40-MHz echocardiography. Circulation 1998;98:912-8.
11. Zhou YQ, Foster FS, Qu DW, Zhang M, Harasiewicz KA, Adamson SL. Applications for multifrequency ultrasound biomicroscopy in mice from implantation to adulthood. Physiol Genomics 2002;10:113-26.
12. Turnbull DH, Ramsay JA, Shivji GS, Bloomfield TS, From L, Sauder DN, et al. Ultrasound backscatter microscope analysis of mouse melanoma progression. Ultrasound Med Biol 1996;22:845-53.
13. Olsson M, Campbell K, Turnbull DH. Specification of mouse telencephalic and mid-hindbrain progenitors following heterotopic ultrasound-guided embryonic transplantation. Neuron 1997;19:761-72.
14. Liu AM, Joyner AL, Turnbull DH. Alteration of limb and brain patterning in early mouse embryos by ultrasound-guided injection of Shh-expressing cells. Mech Dev 1998;75:107-15.
15. Weiner HL, Bakst R, Hurlbert MS, Ruggiero J, Ahn E, Lee WS, et al. Induction of medulloblastomas in mice by Sonic hedgehog, independent of Glil. Cancer Res 2002;62:6385-9.
16. Gaiano N, Kohtz JD, Turnbull DH, Fishell G. A method for rapid gain-of-function studies in the mouse embryonic nervous system. Nat Neurosci 1999;2:812-9.
17. Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res 2002;62:6371-5.
18. Christopher DA, Burns PN, Starkoski BG, Foster FS. A high-frequency pulsed-wave doppler ultrasound system for the detection and imaging of blood flow in the microcirculation. Ultrasound Med Biol 1997;23:997-1015.
19. Berube LR, Harasiewicz K, Foster FS, Dobrowsky E, Sherar MD, Rauth AM. Use of a high-frequency ultrasound microscope to image the action of 2-nitroimidazoles in multicellular spheroids. Br J Cancer 1992;65:633-40.
20. Sherar MD, Noss MB, Foster FS. Ultrasound backscatter microscopy images the internal structure of living tumor spheroids. Nature 1987;330:493-5.
21. Czarnota GJ, Kolios MC, Vaziri H, Benchimol S, Ottensmeyer FP, Sherar MD, et al. Ultrasonic biomicroscopy of viable, dead and apoptotic cells. Ultrasound Med Biol 1997;23:961-5.
22. Czarnota GJ, Kolios MC, Abraham J, Portnoy M, Ottensmeyer FP, Hunt JW, et al. Ultrasound imaging of apoptosis: high-resolution non-invasive monitoring of programmed cell death in vitro, in situ and in vivo. Br J Cancer 1999;81:520-7.
23. Hunt JW, Worthington AE, Xuan A, Kolios MC, Czarnota GJ, Sherar MD. A model based upon pseudo regular spacing of cells combined with the randomisation of the nuclei can explain the significant changes in high-frequency ultrasound signals during apoptosis. Ultrasound Med Biol 2002;28:217-26.
24. Bereiter-Hahn J, Luers H. The role of elasticity in the motile behaviour of cells. NATO ASI ser. Ser H Cell Biol 1994;84:181-230.
25. Bereiter-Hahn J, Luers H. Subcellular tension fields, mechanical resistance of the lamella front related to the direction of locomotion. Cell Biochem Biophys 1998;29: 242-62.
26. Bereiter-Hahn J. Probing biological cells and tissues with acoustic microscopy. Adv Acoustic Microsc 1995;1: 79-15.
27. Sarvazyan AP, Scovoroda A, Vucelic D. Utilisation of surface acoustic waves and shear acoustic properties for imaging and tissue characterisation. In: Ermert H, Harjes HP, editors. Acoustical imaging. New York: Plenum Press, 1992:463-8.
28. Sasaki H, Saijo Y, Tanaka M, Okawai H, Terasawa Y, Yambe T, et al. Influence of tissue preparation on the high-frequency acoustic properties of normal kidney tissue. Ultrasound Med Biol 1996;22:1261-5.
29. Kundu T, Bereiter-Hahn J, Karl I. Cell property determination from the acoustic microscope generated voltage versus frequency curves. Biophys J 2000;78:2270-9.
30. Hildebrand JA, Rugar D, Johnston RN, Quate CF. Acoustic microscopy of living cells. Proc Natl Acad Sci USA Biol Sci 1981;78:1656-60.
31. Hildebrand JA, Rugar D. Measurement of cellular elastic properties by acoustic microscopy. J Microsc Oxf 1984;134:245-60.
32. Litniewski J, Bereiter-Hahn J. Measurements of cells in culture by scanning acoustic microscopy. J Microsc Oxf 1990;158:95-107.
33. Acoustic velocity determination in cytoplasm by V(z) shift. In: Ermert H, Harjes HP, editors. Acoustical Imaging. New York: Plenum Press, 1992:535-8.
34. Kundu T, Bereiter-Hahn J, Hillmann K. Measuring elastic properties of cells by evaluation of scanning acoustic microscopy V(Z) values using simplex algorithm. Biophys J 1991;59:1194-207.
35. Kundu T, Bereiter-Hahn J, Hillman K. Calculating acoustical properties of cells - influence of surface-topography, liquid layer between cell and substrate. J Acoust Soc Am 1992;91:3008-17.
36. Barr RJ, White GM, Jones JP, Shaw LB, Ross PA. Scanning acoustic microscopy of neoplastic and inflammatory cutaneous tissue specimens. J Invest Dermatol 1991;96:38-42.
37. Jones JP. Applications of acoustical microscopy in dermatology. In: Dunn F, editor. Ultrasonic tissue characterization. New York: Springer-Verlag, 1996:201-12.
38. Saijo Y, Tanaka M, Okawai H, Dunn F. The ultrasonic properties of gastric-cancer tissues obtained with a scanning acoustic microscope system. Ultrasound Med Biol 1991;17:709-14.
39. Rubin JM, Adler RS, Fowlkes JB, Spratt S, Pallister JE, Chen JF, et al. Fractional moving blood-volume - estimation with power Doppler US. Radiology 1995;197:183-90.
40. Peters-Engl C, Medl M, Mirau M, Wanner C, Bilgi S, Sevelda P, et al. Color-coded and spectral Doppler flow in breast carcinomas - relationship with the tumor microvasculature. Breast Cancer Res Treat 1998;47:83-9.
41. Gee MS, Saunders HM, Lee JC, Sanzo JF, Jenkins WT, Evans SM, et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res 2001;61:2974-82.
42. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress Radiology 1996;198:679-86.
43. Halpern EJ, Rosenberg M, Gomella LG. Prostate cancer: contrast-enhanced US for detection. Radiology 2001;219:219-25.
44. Bertolotto M, Dalla Palma L, Quaia E, Locatelli M. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 2000;10:1369-76.
45. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000;216: 411-7.
46. Blomley MJK, Albrecht H, Cosgrove PO, Jayaram V, Eckersley RJ, Patel N, et al. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology 1998;209: 862-6.
47. Albrecht T, Blomley MJK, Cosgrove DO, Taylor-Robinson SD, Jayaram V, Eckersley R, et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999;353:1579-83.
48. Blomley MJK, Lim AKP, Harvey CJ, Patel N, Eckersley RJ, Basilico R, et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study. Gut 2003;52:1188-93.
49. Harvey CJ, Blomley MJ, Cosgrove DO, Eckersley RJ, Heckemann RA, Butler-Barnes JA. Can liver vascular transit time measured with bolus injections of the microbubble Levovist predict the presence of occult metastases in colorectal cancer? Radiology 2000;217:816.
50. Lindner JR, Coggins MP, Kaul S, Klibanov AL, Brandenburger GH, Ley K. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. Circulation 2000;101: 668-75.
51. Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Prog Cardiovasc Dis 2001;44:13-31.
52. Kono Y, Steinbach GC, Peterson T, Schmid-Schonbein GW, Mattrey RF. Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intravital microscopy study in rats. Radiology 2002;224:253-7.
53. Forsberg F, Goldberg BB, Liu JB, Merton DA, Rawool NM, Shi WT. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. Radiology 1999;210:125-32.
54. Villanueva FS, Jankowski RJ, Manaugh C, Wagner WR. Albumin microbubble adherence to human coronary endothelium: implications for assessment of endothelial function using myocardial contrast echocardiography. J Am Coll Cardiol 1997;30:689-93.
55. Lindner JR, Dayton PA, Coggins MP, Ley K, Song J, Ferrara K, et al. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 2000;102:531-8.
56. Lindner JR, Song J, Xu F, Klibanov AL, Singbartl K, Ley K, et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000;102:2745-50.
57. Walzog B, Schuppan D, Heimpel C, Hafezimoghadam A, Gaehtgens P, Ley K. The leukocyte integrin Mac-1 (Cd11b/Cd18) contributes to binding of human granulocytes to collagen. Exp Cell Res 1995;218:28-38.
58. Davis GE. The Mac-1 and P150,95 Beta-2 integrins bind denatured proteins to mediate leukocyte cell substrate adhesion. Exp Cell Res 1992;200:242-52.
59. Dayton PA, Chomas JE, Lum AFH, Allen JS, Lindner JR, Simon SI, et al. Optical and acoustical dynamics of microbubble contrast agents inside neutrophils. Biophys J 2001;80:1547-56.
60. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC, et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998;98:1-5.
61. Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001;104:2107-12.
62. Barbarese E, Ho SY, Darrigo JS, Simon RH. Internalization of microbubbles by tumor-cells in-vivo and in-vitro. J Neurooncol 1995;26:25-34.
63. Ho SY, Barbarese E, Darrigo JS, SmithSlatas C, Simon RH. Evaluation of lipid-coated microbubbles as a delivery vehicle for taxol in brain tumor therapy. Neurosurgery 1997;40: 1260-6.
64. Wakefield AE, Ho SY, Li XG, D'Arrigo JS, Simon RH. The use of lipid-coated microbubbles as a delivery agent of 7 beta-hydroxycholesterol in a radiofrequency lesion in the rat brain. Neurosurgery 1998;42:592 8.
65. Ellegala DB, Poi HL, Carpenter JE, Klibanov AL, Kaul S, Shaffrey ME, et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)-beta(3). Circulation 2003;108:336-41.
66. Patel D, Dayton P, Gut J, Wisner E, Ferrara KW. Optical and acoustical interrogation of submicron contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 2002;49:1641-51.
67. Unger EC, McCreery TP, Sweitzer RH, Shen DK, Wu GL. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 1998;81:58G-61G.
68. Wright WH, McCreery TP, Krupinski EA, Lund PJ, Smyth SH, Baker MR, et al. Evaluation of new thrombus-specific ultrasound contrast agent. Acad Radiol 1998;5:S240-S242.
69. Takeuchi M, Ogunyankin K, Pandian NG, McCreery TP, Sweitzer RH, Caldwell VE, et al. Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): in vivo experimental echocardiographic studies. J Am Soc Echocardiogr 1999;12:1015-21.
70. Schumann PA, Christiansen JP, Quigley RM, McCreery TP, Sweitzer RH, Unger EC, et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 2002;37:587-93.
71. Ruoslahti E. RGD and other recognition sequences for integrins. Ann Rev Cell Dev Biol 1996;12:697-715.
72. Wu YQ, Unger EC, McCreery TP, Sweitzer RH, Shen DK, Wu GL, et al. Binding and lysing of blood clots using MRX-408. Invest Radiol 1998;33:880-5.
73. Alkan-Onyuksel H, Demos SM, Lanza GM, Vonesh MJ, Klegerman ME, Kane BJ, et al. Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci 1996;85:486-90.
74. Demos SM, Onyuksel H, Gilbert J, Roth SI, Kane B, Jungblut P, et al. In vitro targeting of antibody-conjugated echogenic liposomes for site-specific ultrasonic image enhancement. J Pharm Sci 1997;86:167-71.
75. Demos SM, Dagar S, Klegerman M, Nagaraj A, McPherson DD, Onyuksel H. In vitro targeting of acoustically reflective immunoliposomes to fibrin under various flow conditions. J Drug Target 1998;5:507-18.
76. Demos SM, Alkan-Onyuksel H, Kane BJ, Ramani K, Nagaraj A, Greene R, et al. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol 1999;33:867-75.
77. Huang SL, Hamilton AJ, Pozharski E, Nagaraj A, Klegerman ME, McPherson DD, et al. Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol 2002;28:339-48.
78. Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996;94:3334-40.
79. Lanza GM, Wallace KD, Fischer SE, Christy DH, Scott MJ, Trousil RL, et al. High-frequency ultrasonic detection of thrombi with a targeted contrast system. Ultrasound Med Biol 1997;23:863-70.
80. Lanza GM, Abendschein DR, Hall CS, Scott MJ, Scherrer DE, Houseman A, et al. In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. J Am Soc Echocardiogr 2000; 13:608-14.
81. Lanza GM, Abendschein DR, Hall CS, Marsh JN, Scott MJ, Scherrer DE, et al. Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest Radiol 2000;35:227-34.
82. Lanza GM, Trousil RL, Wallace KD, Rose JH, Hall CS, Scott MJ, et al. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am 1998;104:3665-72.
83. Hall CS, Marsh JN, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Time evolution of enhanced ultrasonic reflection using a fibrin-targeted nanoparticulate contrast agent. J Acoust Soc Am 2000;108:3049-57.
84. Hall CS, Marsh JN, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Temperature dependence of ultrasonic enhancement with a site-targeted contrast agent. J Acoust Soc Am 2001;110:1677-84.
85. Hall CS, Lanza GM, Rose JH, Kaufmann RJ, Fuhrhop RW, Handley SH, et al. Experimental determination of phase velocity of perfluorocarbons: applications to targeted contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 2000;47:75-84.
86. Marsh JN, Hall CS, Scott MJ, Fuhrhop RW, Gaffney PJ, Wickline SA, et al. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model. IEEE Trans Ultrason Ferroelectr Freq Control 2002;49:29-38.
87. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, et al. Novel MRI contrast agent for molecular imaging of fibrin implications for detecting vulnerable plaques. Circulation 2001;104:1280-5.
88. Fechheimer M, Boylan JF, Parker S, Sisken JE, Patel GL, Zimmer SG. Transfection of mammalian-cells with plasmid DNA by scrape loading and sonication loading. Proc Natl Acad Sci USA 1987;84:8463-7.
89. Miller DL, Bao SP, Morris JE. Sonoporation of cultured cells in the rotating tube exposure system. Ultrasound Med Biol 1999;25:143-9.
90. Fechheimer M, Denny C, Murphy RF, Taylor DL. Measurement of cytoplasmic Ph in dictyostelium discoideum by using a new method for introducing macromolecules into living cells. Eur J Cell Biol 1986;40:242-7.
91. Guzman HR, Nguyen DX, Khan S, Prausnitz MR. Ultrasound-mediated disruption of cell membranes. I. Quantification of molecular uptake and cell viability. J Acoust Soc Am 2001;110:588-96.
92. Guzman HR, Nguyen DX, Khan S, Prausnitz MR. Ultrasound-mediated disruption of cell membranes. II. Heterogeneous effects on cells. J Acoust Soc Am 2001;110:597-606.
93. Bao SP, Thrall BD, Miller DL. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol 1997;23:953-9.
94. Harrison GH, BalcerKubiczek EK, Gutierrez PL. In vitro mechanisms of chemopotentiation by tone-burst ultrasound. Ultrasound Med Biol 1996;22:355-62.
95. Kodama T, Takayama K. Dynamic behavior of bubbles during extracorporeal shock-wave lithotripsy. Ultrasound Med Biol 1998;24:723-38.
96. Kodama T, Tomita, Y. Cavitation bubble behavior and bubble-shock wave interaction near a gelatin surface as a study of in vivo bubble dynamics. Appl Phys B-Lasers Opt 2000;70:139-49.
97. Shohet RV, Chen SY, Zhou YT, Wang ZW, Meidell RS, Unger TH, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000;101:2554-6.
98. Chen SY, Shohet RV, Frenkel P, Mayer S, Unger RH, Grayburn PA. Successful expression of plasmid DNA in rat myocardium by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2001;37:407A.
99. Chen SY, Shohet RV, Bekeredjian R, Frenkel P, Grayburn PA. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003;42:301-8.
100. Beeri R, Guerrero JL, Supple G, Sullivan S, Levine RA, Hajjar RJ. New efficient catheter-based system for myocardial gene delivery. Circulation 2002;106:1756-9.
101. Anwer K, Kao G, Proctor B, Anscombe I, Florack V, Earls R, et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther 2000;7:1833-9.
102. Teupe C, Richter S, Fisslthaler B, Randriamboavonjy V, Ihling C, Fleming I, et al. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity. Circulation 2002;105:1104-9.
103. Lu QL, Liang HD, Partridge T, Blomley MJK. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther 2003;10:396-405.
104. Taniyama Y, Tachibana K, Hiraoka K, Aoki M, Yamamoto S, Matsumoto K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002;9:372-80.
105. Azuma H, Tomita N, Kaneda Y, Koike H, Ogihara T, Katsuoka Y, et al. Transfection of NF kappa B-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 2003;10:415-25.